By Colin Kellaher Medical-technology company Enovis has struck a deal to buy orthopedic-implant company LimaCorporate for about 800 million euros ($850.
Enovis (NYSE:ENOV – Get Free Report) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.22-2.36 for the period, compared to the consensus EPS estimate of $2.32. Enovis Price Performance ENOV opened at $53.59 on Friday. Enovis has a one year low of $43.88 and a one […]
Shares of Enovis Co. (NYSE:ENOV – Get Free Report) have been assigned an average rating of “Buy” from the seven research firms that are currently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued ratings on the stock […]
Enovis Co. (NYSE:ENOV – Free Report) – KeyCorp decreased their Q3 2023 earnings per share estimates for Enovis in a report released on Thursday, August 3rd. KeyCorp analyst M. Mishan now expects that the company will post earnings of $0.50 per share for the quarter, down from their previous estimate of $0.52. The consensus estimate […]
Enovis (NYSE:ENOV – Free Report) had its price objective increased by Robert W. Baird from $67.00 to $70.00 in a report issued on Friday morning, Marketbeat.com reports. They currently have an outperform rating on the stock. A number of other research firms also recently issued reports on ENOV. Wells Fargo & Company upgraded shares of […]